US 8759301
Gene fusion targeted therapy
granted A61KA61K38/00A61P
Quick answer
US patent 8759301 (Gene fusion targeted therapy) held by THE REGENTS OF THE UNIVERSITY OF MICHIGAN expires Mon Jun 19 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- THE REGENTS OF THE UNIVERSITY OF MICHIGAN
- Grant date
- Tue Jun 24 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 19 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 2
- CPC classes
- A61K, A61K38/00, A61P, A61P35/00, A61P43/00